Grants per year
Personal profile
Research Interests
Inflammatory bowel disease (Crohn's disease and ulcerative colitis), therapeutic drug monitoring, clinical trials
Training Experience
| 2011 | Residency, Boston University Medical Center |
| 2014 | Fellowship, University of Chicago |
| 2015 | Fellowship, Northwestern University, Feinberg School of Medicine |
Education/Academic qualification
Medicine, MD, Federal University of Ceara, Brazil
… → 2006
Research interests
- Inflammatory Bowel Disease
Fingerprint
Dive into the research topics where Emanuelle Araujo Lima Bellaguarda is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Prot# Cx601-0303: A phase III, randomized, double blind, parallel group, placebo controlled, international, multicentre study to assess efficacy and safety of Cx601, adult allogeneic expanded adipose-derived stem cells (eASC), for the treatment of complex
Bellaguarda, E. A. L. & Hanauer, S. B.
7/30/21 → 7/30/24
Project: Research project
-
Checkpoint Inhibitor-Induced Colitis
Bellaguarda, E. & Hanauer, S., Feb 1 2020, In: The American journal of gastroenterology. 115, 2, p. 202-210 9 p.Research output: Contribution to journal › Article › peer-review
Open Access14 Scopus citations -
Disordered Eating, Body Dissatisfaction, and Psychological Distress in Patients with Inflammatory Bowel Disease (IBD)
Wabich, J., Bellaguarda, E., Joyce, C., Keefer, L. & Kinsinger, S., Jun 1 2020, In: Journal of Clinical Psychology in Medical Settings. 27, 2, p. 310-317 8 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Recurrent brisk haematochezia in a patient with quiescent Crohn's disease
Gasanova, Z., Lemmer, A. & Bellaguarda, E., Jan 1 2020, (Accepted/In press) In: Frontline Gastroenterology. flgastro-2019-101404.Research output: Contribution to journal › Article › peer-review
-
Epidemiology and implications of concurrent diagnosis of eosinophilic oesophagitis and IBD based on a prospective population-based analysis
Limketkai, B. N., Shah, S. C., Hirano, I., Bellaguarda, E. & Colombel, J. F., Dec 1 2019, In: Gut. 68, 12, p. 2152-2160 9 p.Research output: Contribution to journal › Article › peer-review
16 Scopus citations -
Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease
Christensen, B., Micic, D., Gibson, P. R., Yarur, A., Bellaguarda, E., Corsello, P., Gaetano, J. N., Kinnucan, J., Rao, V. L., Reddy, S., Singh, S., Pekow, J. & Rubin, D. T., Mar 2018, In: Alimentary Pharmacology and Therapeutics. 47, 6, p. 753-762 10 p.Research output: Contribution to journal › Article › peer-review
39 Scopus citations